According to Fortune Business Insights, the global conjunctivitis treatment market was valued at USD 3.85 billion in 2019 and is projected to reach USD 4.38 billion by 2027, exhibiting a CAGR of 3.7% during the forecast period. In 2019, North America dominated the conjunctivitis treatment market with a market share of 48.05%.